Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development.
Alternative splicing is an important mechanism for the generation of protein diversity at a post-transcriptional level. Modifications in the splicing patterns of several genes have been shown to contribute to the malignant transformation of different tissue types. In this study, we used the Affymetrix Exon arrays to investigate patterns of differential splicing between pediatric medulloblastomas and normal cerebellum on a genome-wide scale. Of the 1,262 genes identified as potentially generating tumor-associated splice forms, we selected 14 examples of differential splicing of known cassette exons and successfully validated 11 of them by reverse transcriptase PCR. The pattern of differential splicing of three validated events was characteristic for the molecular subset of sonic hedgehog (Shh)-driven medulloblastomas, suggesting that their unique gene signature includes the expression of distinctive transcript variants. Generally, we observed that tumor and normal fetal cerebellar samples shared significantly lower exon inclusion rates than normal adult cerebellum. We investigated whether tumor-associated splice forms were expressed in primary cultures of Shh-dependent mouse cerebellar granule cell precursors (GCP) and found that Shh caused a decrease in the cassette exon inclusion rate of five of the seven tested genes. Furthermore, we observed a significant increase in exon inclusion between postnatal days 7 and 14 of mouse cerebellar development, at the time when GCPs mature into postmitotic neurons. We conclude that inappropriate splicing frequently occurs in human medulloblastomas and may be linked to the activation of developmental signaling pathways and a failure of cerebellar precursor cells to differentiate.
Molecular Haematology and Cancer Biology Unit and Neural Development Unit, UCL Institute of Child Health, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom.
Francesca
F
Menghi
Thomas S
TS
Jacques
Martino
M
Barenco
Ed C
EC
Schwalbe
Steven C
SC
Clifford
Mike
M
Hubank
Jonathan
J
Ham
D017398:Alternative Splicing; D000818:Animals; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D002528:Cerebellar Neoplasms / Q000235:genetics*; D002531:Cerebellum / Q000254:growth & development / Q000378:metabolism*; D016000:Cluster Analysis; D020869:Gene Expression Profiling; D018507:Gene Expression Regulation, Developmental; D015972:Gene Expression Regulation, Neoplastic; D016678:Genome / Q000235:genetics; D055106:Genome-Wide Association Study; D057809:HEK293 Cells; D006801:Humans; D008527:Medulloblastoma / Q000235:genetics* / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D020411:Oligonucleotide Array Sequence Analysis; D020033:Protein Isoforms / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction
D020033:Protein Isoforms
BMC Dev Biol. 2007 Oct 09;7:111
17925019
Nucleic Acids Res. 2008 Jan;36(Database issue):D780-6
17932061
Neuron. 2000 Feb;25(2):359-71
10719891
Genes Cells. 2007 Nov;12(11):1255-65
17986009
J Clin Oncol. 2003 Sep 1;21(17):3255-61
12947060
Cancer Res. 2007 Jun 15;67(12):5635-42
17575129
Cell. 2009 Sep 4;138(5):898-910
19737518
Neuropathol Appl Neurobiol. 2007 Feb;33(1):67-76
17239009
Am J Physiol. 1992 Feb;262(2 Pt 1):C461-9
1539634
Cell. 2008 Jul 11;134(1):162-74
18614019
J Biomol Tech. 2010 Apr;21(1):44-53
20357982
J Immunol. 2009 Nov 15;183(10):6422-31
19880447
BMC Genomics. 2008 Nov 07;9:529
18990248
Int J Biochem Cell Biol. 2007;39(7-8):1432-49
17416541
Biotechniques. 1994 Oct;17(4):652-5
7833018
J Biol Chem. 1997 Dec 12;272(50):31589-97
9395497
Lancet Oncol. 2007 Apr;8(4):349-57
17395108
Oncogene. 2006 Oct 12;25(47):6252-61
16682944
Oncogene. 2006 Nov 23;25(55):7267-73
16878160
J Neurosci. 2008 Dec 3;28(49):13310-9
19052223
Exp Cell Res. 2002 May 1;275(2):155-70
11969287
BMC Bioinformatics. 2009 Jan 20;10:26
19154578
Cancer Res. 2008 Sep 15;68(18):7352-61
18794122
Nucleic Acids Res. 2003 Feb 15;31(4):e15
12582260
Ann Neurol. 2006 Jul;60(1):3-11
16802285
Cancer. 2002 Jan 15;94(2):552-60
11900240
Acta Neuropathol. 2007 Aug;114(2):97-109
17618441
Neuron. 1999 Jan;22(1):103-14
10027293
J Clin Oncol. 2006 Apr 20;24(12):1924-31
16567768
Oncogene. 2004 Feb 5;23(5):1076-87
14716293
Cancer Res. 2010 Feb 1;70(3):896-905
20103641
Nucleic Acids Res. 2006;34(15):e103
16951290
PLoS One. 2008 Aug 28;3(8):e3088
18769486
Science. 2003 Dec 19;302(5653):2141-4
14684825
Genes Dev. 2010 Nov 1;24(21):2343-64
21041405
Cell Stem Cell. 2010 Jan 8;6(1):37-47
20085741
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10779-84
8855257
Genes Dev. 2007 Jul 1;21(13):1636-52
17606642
BMC Bioinformatics. 2007 Jun 04;8:180
17547750
Biochem Soc Trans. 2007 Nov;35(Pt 5):919-22
17956246
J Biol Chem. 2004 Mar 12;279(11):10593-605
14676205
Lancet Neurol. 2007 Dec;6(12):1073-85
18031705
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
BMC Genomics. 2006 Dec 27;7:325
17192196
J Neurobiol. 2006 Jun;66(7):739-56
16688769
Genome Biol. 2007;8(4):R64
17456239
Oncogene. 2007 Aug 13;26(37):5358-72
17694078
J Mol Biol. 2007 Jun 22;369(5):1258-69
17482208
Clin Biochem. 2004 Jul;37(7):584-94
15234240